Evaluating nurses' implementation of an infant-feeding counseling protocol for HIV-infected mothers: The Ban Study in Lilongwe, Malawi.

The health of HIV-exposed children after early weaning. Matern Child Nutr (2011) 2.01

Retracted Process evaluation of a positive youth development program in Hong Kong based on different cohorts. ScientificWorldJournal (2012) 1.37

A lipid-based nutrient supplement mitigates weight loss among HIV-infected women in a factorial randomized trial to prevent mother-to-child transmission during exclusive breastfeeding. Am J Clin Nutr (2012) 1.18

Use of lipid-based nutrient supplements by HIV-infected Malawian women during lactation has no effect on infant growth from 0 to 24 weeks. J Nutr (2012) 0.93

The acceptance and feasibility of replacement feeding at 6 months as an HIV prevention method in Lilongwe, Malawi: results from the BAN study. AIDS Educ Prev (2011) 0.91

Maternal weight loss during exclusive breastfeeding is associated with reduced weight and length gain in daughters of HIV-infected Malawian women. J Nutr (2013) 0.84

Theory-driven process evaluation of a complementary feeding trial in four countries. Health Educ Res (2014) 0.83

Antiretroviral Treatment Is Associated With Iron Deficiency in HIV-Infected Malawian Women That Is Mitigated With Supplementation, but Is Not Associated With Infant Iron Deficiency During 24 Weeks of Exclusive Breastfeeding. J Acquir Immune Defic Syndr (2015) 0.78

Changes in soluble transferrin receptor and hemoglobin concentrations in Malawian mothers are associated with those values in their exclusively breastfed, HIV-exposed infants. J Nutr (2013) 0.78

Thiamin and Riboflavin in Human Milk: Effects of Lipid-Based Nutrient Supplementation and Stage of Lactation on Vitamer Secretion and Contributions to Total Vitamin Content. PLoS One (2016) 0.77

Lipid-based nutrient supplements are feasible as a breastmilk replacement for HIV-exposed infants from 24 to 48 weeks of age. J Nutr (2013) 0.77

Process evaluation of a psychosocial intervention addressing women in a disadvantaged setting. Glob J Health Sci (2011) 0.75

Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. J Infect Dis (2004) 5.93

Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis (1999) 3.69

Preventing HIV transmission to children: quality of counselling of mothers in South Africa. Acta Paediatr (2005) 3.31

Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. J Infect Dis (2000) 3.02

Qualitative analysis: what it is and how to begin. Res Nurs Health (1995) 2.60

Modifications of a large HIV prevention clinical trial to fit changing realities: a case study of the Breastfeeding, Antiretroviral, and Nutrition (BAN) protocol in Lilongwe, Malawi. Contemp Clin Trials (2008) 2.35

Structured observations of hygiene behaviours in Burkina Faso: validity, variability, and utility. Bull World Health Organ (1993) 2.19

Late postnatal mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire. Lancet (1997) 2.12

Avoiding type III errors in health education program evaluations: a case study. Health Educ Q (1985) 2.06

HIV and infant feeding counselling: challenges faced by nurse-counsellors in northern Tanzania. Hum Resour Health (2007) 1.94

Counsellors' perspectives on antenatal HIV testing and infant feeding dilemmas facing women with HIV in northern Tanzania. Reprod Health Matters (2002) 1.88

Evaluation of health education programs: current assessment and future directions. Health Educ Q (1995) 1.71

Design of process evaluation within the Child and Adolescent Trial for Cardiovascular Health (CATCH). Health Educ Q (1994) 1.65

Breast-feeding and Transmission of HIV-1. J Acquir Immune Defic Syndr (2004) 1.56

Promoting breastfeeding in rural Gambia: combining traditional and modern knowledge. Health Policy Plan (2001) 1.45

Involving communities in the design of clinical trial protocols: the BAN Study in Lilongwe, Malawi. Contemp Clin Trials (2006) 1.45

Differences between international recommendations on breastfeeding in the presence of HIV and the attitudes and counselling messages of health workers in Lilongwe, Malawi. Int Breastfeed J (2006) 1.32

Infant feeding in the time of HIV: rapid assessment of infant feeding policy and programmes in four African countries scaling up prevention of mother to child transmission programmes. Arch Dis Child (2007) 1.31

An education and counseling program for preventing breast-feeding-associated HIV transmission in Zimbabwe: design and impact on maternal knowledge and behavior. J Nutr (2005) 1.19

Experiences of breastfeeding and vulnerability among a group of HIV-positive women in Durban, South Africa. Health Policy Plan (2000) 1.18

Use of antiretroviral drugs to prevent HIV-1 transmission through breast-feeding: from animal studies to randomized clinical trials. J Acquir Immune Defic Syndr (2004) 1.16

Perceptions of the role of maternal nutrition in HIV-positive breast-feeding women in Malawi. J Nutr (2005) 1.16

Women's voices, women's choices: the challenge of nutrition and HIV/AIDS. J Nutr (2005) 1.12

Effect of a mother-to-child HIV prevention programme on infant feeding and caring practices in South Africa. S Afr Med J (2002) 1.12

Breastfeeding promotion in Kenya: changes in health worker knowledge, attitudes and practices, 1982-89. J Trop Pediatr (1992) 1.09

One is the liveliest number: the case orientation of qualitative research. Res Nurs Health (1996) 0.98

HIV transmission through breastfeeding: problems and prevention. Ann Trop Paediatr (2003) 0.95

Process measures in an antenatal smoking cessation trial: another part of the picture. Health Educ Res (2000) 0.91

Previous BFHI training and nurses' knowledge, attitudes and practices regarding exclusive breastfeeding. Afr J Med Med Sci (2002) 0.89

Promotion of breast feeding in the community: impact of health education programme in rural communities in Nigeria. J Diarrhoeal Dis Res (1996) 0.85

Process Evaluation in the Community Intervention Trial for Smoking Cessation (COMMIT). Int Q Community Health Educ (1990) 0.77

Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med (2011) 69.36

Patterns of somatic mutation in human cancer genomes. Nature (2007) 38.41

Signatures of mutational processes in human cancer. Nature (2013) 21.63

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet (2008) 19.65

A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature (2009) 18.39

Preexposure prophylaxis for HIV infection among African women. N Engl J Med (2012) 15.28

Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature (2010) 14.50

Maternal and child undernutrition: consequences for adult health and human capital. Lancet (2008) 13.31

Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature (2011) 13.30

The landscape of cancer genes and mutational processes in breast cancer. Nature (2012) 11.24

Mutational processes molding the genomes of 21 breast cancers. Cell (2012) 11.22

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med (2011) 10.79

The life history of 21 breast cancers. Cell (2012) 10.59

Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat Genet (2009) 10.21

Synthesising qualitative and quantitative evidence: a review of possible methods. J Health Serv Res Policy (2005) 9.26

Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med (2010) 8.51

A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation. Nat Genet (2009) 8.30

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med (2004) 7.67

Somatic mutations of the protein kinase gene family in human lung cancer. Cancer Res (2005) 7.66

An open letter to The BMJ editors on qualitative research. BMJ (2016) 7.49

Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care (2008) 7.27

A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy. Cancer Res (2006) 6.91

A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer. Nat Genet (2005) 6.70

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med (2012) 6.64

Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med (2011) 6.42

Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials. Lancet (2008) 6.28

Women's groups practising participatory learning and action to improve maternal and newborn health in low-resource settings: a systematic review and meta-analysis. Lancet (2013) 6.15

Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS (2005) 6.10

Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA (2010) 5.94

Estimation of potential effects of improved community-based drug provision, to augment health-facility strengthening, on maternal mortality due to post-partum haemorrhage and sepsis in sub-Saharan Africa: an equity-effectiveness model. Lancet (2009) 5.88

The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet (2011) 5.87

Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial. Lancet (2010) 5.41

Population-based study of chlamydial infection in China: a hidden epidemic. JAMA (2003) 5.40

Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med (2009) 5.35

Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature (2013) 5.35

Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. Trop Med Int Health (2008) 5.32

Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia. J Virol (2008) 5.24

Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection. N Engl J Med (2003) 4.57

Community participation: lessons for maternal, newborn, and child health. Lancet (2008) 4.55

Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS One (2009) 4.52

Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration. J Womens Health (Larchmt) (2008) 4.38

Pregnancy and infection. N Engl J Med (2014) 4.15

Mutation analysis of 24 known cancer genes in the NCI-60 cell line set. Mol Cancer Ther (2006) 4.09

Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1. Antimicrob Agents Chemother (2003) 4.01

Inpatient hysterectomy surveillance in the United States, 2000-2004. Am J Obstet Gynecol (2007) 3.86

Antiretroviral treatment for children with peripartum nevirapine exposure. N Engl J Med (2010) 3.81

Using vital registration data to update mortality among patients lost to follow-up from ART programmes: evidence from the Themba Lethu Clinic, South Africa. Trop Med Int Health (2010) 3.79

Opportunities and challenges for HIV care in overlapping HIV and TB epidemics. JAMA (2008) 3.78

Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. AIDS (2007) 3.72

Performance of an oral fluid rapid HIV-1/2 test: experience from four CDC studies. AIDS (2006) 3.70

Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 Infection. N Engl J Med (2015) 3.64

Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study. Lancet (2005) 3.48

Fertility treatments and multiple births in the United States. N Engl J Med (2013) 3.45

Child mortality according to maternal and infant HIV status in Zimbabwe. Pediatr Infect Dis J (2007) 3.40

Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa. Trop Med Int Health (2010) 3.34

The power and the promise: working with communities to analyze data, interpret findings, and get to outcomes. Am J Public Health (2008) 3.29

What can intervention studies tell us about the relationship between fruit and vegetable consumption and weight management? Nutr Rev (2004) 3.27

Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis. AIDS (2007) 3.22

The burden of selected chronic non-communicable diseases and their risk factors in Malawi: nationwide STEPS survey. PLoS One (2011) 3.21

Detection of acute HIV infection: a field evaluation of the determine® HIV-1/2 Ag/Ab combo test. J Infect Dis (2011) 3.16

The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa. Trop Med Int Health (2008) 3.16

Antiretroviral therapies in women after single-dose nevirapine exposure. N Engl J Med (2010) 3.14

Cost-effectiveness of HIV treatment as prevention in serodiscordant couples. N Engl J Med (2013) 3.10

First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial. Lancet Infect Dis (2011) 3.04

Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals. Public Health Rep (2005) 2.97

CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals. Nat Med (2008) 2.94

Extending CATH: increasing coverage of the protein structure universe and linking structure with function. Nucleic Acids Res (2010) 2.93

An enhanced method for identifying obstetric deliveries: implications for estimating maternal morbidity. Matern Child Health J (2007) 2.89

The impact and cost of scaling up GeneXpert MTB/RIF in South Africa. PLoS One (2012) 2.88

Burden of cancer in Malawi; common types, incidence and trends: national population-based cancer registry. BMC Res Notes (2012) 2.88

Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis. PLoS One (2011) 2.84

Predictors of proteinuria and renal failure among women with HIV infection. Kidney Int (2002) 2.83

Rapid HIV-1 testing during labor: a multicenter study. JAMA (2004) 2.81

Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst (2003) 2.81

Pandemic influenza and pregnant women. Emerg Infect Dis (2008) 2.80

Developing a theory-based taxonomy of methods for implementing change in practice. J Adv Nurs (2007) 2.78

Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study. PLoS Med (2011) 2.76

Safety and efficacy of HIV hyperimmune globulin for prevention of mother-to-child HIV transmission in HIV-1-infected pregnant women and their infants in Kampala, Uganda (HIVIGLOB/NVP STUDY). J Acquir Immune Defic Syndr (2011) 2.75

Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel. PLoS Med (2008) 2.74